ITRM ITERUM THERAPEUTICS PLC Management Changes 8-K Filing 2025 - Board Appointments On March 7, 2025, Iterum Therapeutics appointed Joseph J. Whalen to its Board of Directors and David Kelly as Chairman, effective March 10, 2025, ensuring compliance with Nasdaq's audit committee requirements.Get access to all SEC 8-K filings of the ITERUM THERAPEUTICS PLC